UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients — Stella

Recruiting

Back to SLE trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Medical University of South Carolina, Charleston, South Carolina

Key details

Phase

Early testing

Sponsor

LiveKidney.Bio

Collaborators

Medical University of South Carolina, Galilee CBR

Enrollment target

~10 participants

Started

January 2025

Primary completion

June 2026

Age range

18 Years – 75 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov